Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 17 results.
User Information
Export Records
  1. 1.   Modifications of Glycans: Biological Significance and Therapeutic Opportunities
  2. Muthana, S. M.; Campbell, C. T.; Gildersleeve, J. C.
  3. Acs Chemical Biology. 2012, Jan; 7(1): 31-43.
  1. 2.   Application of a Novel Score Test for Genetic Association Incorporating Gene-Gene Interaction Suggests Functionality for Prostate Cancer Susceptibility Regions
  2. Ciampa, J.; Yeager, M.; Jacobs, K.; Thun, M. J.; Gapstur, S.; Albanes, D.; Virtamo, J.; Weinstein, S. J.; Giovannucci, E.; Willett, W. C.; Cancel-Tassin, G.; Cussenot, O.; Valeri, A.; Hunter, D.; Hoover, R.; Thomas, G.; Chanock, S.; Holmes, C.; Chatterjee, N.
  3. Human Heredity. 2011, Nov; 72(3): 182-193.
  1. 3.   Molecular Aspects of HTLV-1 Entry: Functional Domains of the HTLV-1 Surface Subunit (SU) and Their Relationships to the Entry Receptors
  2. Jones, K. S.; Lambert, S.; Bouttier, M.; Benit, L.; Ruscetti, F. W.; Hermine, O.; Pique, C.
  3. Viruses-Basel. 2011, Jun; 3(6): 794-810.
  1. 4.   Unconventional Secretion of Tissue Transglutaminase Involves Phospholipid-Dependent Delivery into Recycling Endosomes
  2. Zemskov, E. A.; Mikhailenko, I.; Hsia, R. C.; Zaritskaya, L.; Belkin, A. M.
  3. Plos One. 2011, Apr; 6(4): 14.
  1. 5.   Interaction between the HTLV-I envelope and cellular proteins: impact on virus infection and restriction
  2. Ilinskaya, A.; Heidecker, G.; Jones, K.
  3. Future Medicinal Chemistry. 2010, Nov; 2(11): 1651-1668.
  1. 6.   Current concepts regarding the HTLV-1 receptor complex
  2. Ghez, D.; Lepelletier, Y.; Jones, K. S.; Pique, C.; Hermine, O.
  3. Retrovirology. 2010, Nov; 7: 11.
  1. 7.   A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses
  2. Matsumoto, K.; Irie, F.; Mackem, S.; Yamaguchi, Y.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Jun; 107(24): 10932-10937.
  1. 8.   Crystal Structure of the Catalytic Domain of Drosophila beta 1,4-Galactosyltransferase-7
  2. Ramakrishnan, B.; Qasba, P. K.
  3. Journal of Biological Chemistry. 2010, May; 285(20): 15619-15626.
  1. 9.   Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer
  2. Wang, S. S.; Gonzalez, P.; Yu, K.; Porras, C.; Li, Q. Z.; Safaeian, M.; Rodriguez, A. C.; Sherman, M. E.; Bratti, C.; Schiffman, M.; Wacholder, S.; Burk, R. D.; Herrero, R.; Chanock, S. J.; Hildesheim, A.
  3. Plos One. 2010, Jan; 5(1): 7.
  1. 10.   The Receptor Complex Associated with Human T-Cell Lymphotropic Virus Type 3 (HTLV-3) Env-Mediated Binding and Entry Is Distinct from, but Overlaps with, the Receptor Complexes of HTLV-1 and HTLV-2
  2. Jones, K. S.; Huang, Y. K.; Chevalier, S. A.; Afonso, P. V.; Petrow-Sadowski, C.; Bertolette, D. C.; Gessain, A.; Ruscetti, F. W.; Mahieux, R.
  3. Journal of Virology. 2009 83(10): 5244-5255.
  1. 11.   HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF(165)
  2. Lambert, S.; Bouttier, M.; Vassy, R.; Seigneuret, M.; Petrow-Sadowski, C.; Janvier, S.; Heveker, N.; Ruscetti, F. W.; Perret, G.; Jones, K. S.; Pique, C.
  3. Blood. 2009 113(21): 5176-5185.
  1. 12.   GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1
  2. Takenouchi, N.; Jones, K. S.; Lisinski, I.; Fugo, K.; Yao, K.; Cushman, S. W.; Ruscetti, F. W.; Jacobson, S.
  3. Journal of Virology. 2007, Feb; 81(3): 1506-1510.
  1. 13.   Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells
  2. Jones, K. S.; Fugo, K.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D. C.; Lisinski, I.; Cushman, S. W.; Jacobson, S.; Ruscetti, F. W.
  3. Journal of Virology. 2006, Sep; 80(17): 8291-8302.
  1. 14.   Heparan sulfate Proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4(+) T cells
  2. Jones, K. S.; Petrow-Sadowski, C.; Bertolette, D. C.; Huang, Y.; Ruscetti, F. W.
  3. Journal of Virology. 2005, OCT; 79(20): 12692-12702.
  1. 15.   Heparan sulfate proteoglycans are critical for efficient attachment and entry of HTLV-I into Cd4+ T cells
  2. Jones, K. S.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D.; Fugo, K.; Takenouchi, N.; Grant, C. W.; Yao, K.; Jacobson, S.; Ruscetti, F. W.
  3. Aids Research and Human Retroviruses. 2005, MAY; 21(5): 459, Abstract O65-459, Abstract O65.
  1. 16.   Binding, internalization, and membrane incorporation of human immunodeficiency virus-1 at the blood-brain barrier is differentially regulated
  2. Banks, W. A.; Robinson, S. M.; Wolf, K. M.; Bess, J. W.; Arthur, L. O.
  3. Neuroscience. 2004 128(1): 143-153.
  1. 17.   Generation of artificial proteoglycans containing glycosaminoglycan-modified CD44 - Demonstration of the interaction between RANTES and chondroitin sulfate
  2. Wolff, E. A.; Greenfield, B.; Taub, D. D.; Murphy, W. J.; Bennett, K. L.; Aruffo, A.
  3. Journal of Biological Chemistry. 1999 274(4): 2518-2524.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel